Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




High Frequency Ultrasound Device Treats Benign Tumors

By HospiMedica International staff writers
Posted on 21 Sep 2017
A combination of high intensity focused ultrasound (HIFU) and echotherapy can treat benign tumors such as breast fibroadenomas and thyroid nodules.

The Theraclion (Paris, France) EchoPulse device works by delivery of concentrated HIFU directly to the tumor via an image-guided targeting system, resulting in precise tissue necrosis. More...
The heart of the system is the HIFU piezoelectric transducer, with a frequency of 3 MHz, a maximal acoustic power of 125 W, and automatic depth compensation feature. The second ultrasonic system component is a transducer that operates on a frequency range of 7.5-12 MHz, which provides real-time monitoring of the target area.

Both ultrasound components are housed in the visualization and treatment unit (VTU), which also includes an articulated arm for easy positioning on the treatment area, and a motorized head able to perform not only sagittal and transverse slices, but also micro-movements with millimetric precision thanks to finely tuned electromagnetic friction brakes. The system also includes a patient movement detector and a touch-screen user interface that provides step-by-step procedural control.

Also included is a disposable EPack for the cooling system that is replaced before each treatment. The cooling system allows the ultrasound waves to be transmitted without loss or distortion, while at the same time protecting the patient’s skin from the heat of the HIFU waves. It includes a cooling pack, two pumps, a disposable set of tubing, and a pouch containing 500 ml of fluid. The pump circulates the fluid in a closed circuit between the pouch and the VTU, with a temperature sensor to ensure that the fluid is properly cooled; internal pressure is then adjusted accordingly.

“Advantages of the system include non-invasive, scarless treatment under conscious sedation; fast, efficient, and harmless procedural protocols for practitioners; and lower costs of hospitalization for medical centers,” said the company in a statement. “The idea for this technology was developed by EDAP in 1993. Theraclion is partnering with University of Virginia for proceeding with clinical studies.”

HIFU technology is based on nonlinear acoustic mathematical optimization methods to analyze and simulate the propagation of sound in material. The information is then used to enhance the shape of an acoustic lens so that that ultrsound pressure is focused precisely on the location of the tissue to be ablated, while the surrounding tissue retains as little damage as possible.

Related Links:
Theraclion


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
Isolation Stretcher
IS 736
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.